Development of an enzymatic method for site-specific incorporation of desthiobiotin to recombinant proteins in vitro

Analytical Biochemistry

Volumn 331, Issue 2, 2004, Pages 340-348

  Wu, Sau Ching ^a   Wong, Sui Lam ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Affinity purification; Avidin; Biotin ligase; Biotinylation tag; BirA; Desthiobiotin; Desthiobiotinylation; Mass spectrometry; Recombinant proteins; Reversible binding; Streptavidin

Indexed keywords

ACYLATION; BACTERIOLOGY; BIOCHIPS; COENZYMES; COMPUTER SOFTWARE REUSABILITY; ENZYME IMMOBILIZATION; ESCHERICHIA COLI; GLYCOPROTEINS; MASS SPECTROMETRY; PURIFICATION;

AFFINITY PURIFICATION; AVIDIN; BIOTIN LIGASE; BIOTINYLATIONS; BIRA; DESTHIOBIOTIN; DESTHIOBIOTINYLATION; REVERSIBLE BINDING; STREPTAVIDIN;

RECOMBINANT PROTEINS;

AGAROSE; BIOTIN DERIVATIVE; LIGASE; RECOMBINANT PROTEIN; STAPHYLOKINASE; STREPTAVIDIN;

ANALYTIC METHOD; ARTICLE; BACILLUS SUBTILIS; BIOTINYLATION; CATALYSIS; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME RELEASE; ENZYME SUBSTRATE; ESCHERICHIA COLI; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN PURIFICATION; REACTION TIME;

BACILLUS SUBTILIS; ESCHERICHIA COLI;

EID: 3242710297     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.03.056     Document Type: Article

References (38)

1. Green N.M. Avidin and streptavidin. Methods Enzymol. 184:1990;51-67
2. Wilchek M., Bayer E.A. The avidin-biotin complex in bioanalytical applications. Anal. Biochem. 171:1988;1-32
3. Bayer E.A., Wilchek M. Application of avidin-biotin technology to affinity-based separations. J. Chromatogr. 510:1990;3-11
4. Morag E., Bayer E.A., Wilchek M. Reversibility of biotin-binding by selective modification of tyrosine in avidin. Biochem. J. 316:1996;193-199
5. Morag E., Bayer E.A., Wilchek M. Immobilized nitro-avidin and nitro-streptavidin as reusable affinity matrices for application in avidin-biotin technology. Anal. Biochem. 243:1996;257-263
6. Henrikson K.P., Allen S.H., Maloy W.L. An avidin monomer affinity column for the purification of biotin-containing enzymes. Anal. Biochem. 94:1979;366-370
7. Kohanski R.A., Lane M.D. Monovalent avidin affinity columns. Methods Enzymol. 184:1990;194-200
8. Gitlin G., Bayer E.A., Wilchek M. Studies on the biotin-binding site of streptavidin. Tryptophan residues involved in the active site. Biochem. J. 256:1988;279-282
9. Rosano C., Arosio P., Bolognesi M. The X-ray three-dimensional structure of avidin. Biomol. Eng. 16:1999;5-12
10. Green N.M., Toms E.J. The properties of subunits of avidin coupled to sepharose. Biochem. J. 133:1973;687-700
11. Fudem-Goldin B., Orr G.A. 2-Iminobiotin-containing reagent and affinity columns. Methods Enzymol. 184:1990;167-173
12. Orr G.A. The use of the 2-iminobiotin-avidin interaction for the selective retrieval of labeled plasma membrane components. J. Biol. Chem. 256:1981;761-766
13. Hirsch J.D., Eslamizar L., Filanoski B.J., Malekzadeh N., Haugland R.P., Beechem J.M., Haugland R.P. Easily reversible desthiobiotin binding to streptavidin, avidin, and other biotin-binding proteins: uses for protein labeling, detection, and isolation. Anal. Biochem. 308:2002;343-357
14. Hofmann K., Titus G., Montibeller J.A., Finn F.M. Avidin binding of carboxyl-substituted biotin and analogues. Biochemistry. 21:1982;978-984
15. Betz A., Hofsteenge J., Stone S.R. Interaction of the N-terminal region of hirudin with the active-site cleft of thrombin. Biochemistry. 31:1992;4557-4562
16. Lazar J.B., Winant R.C., Johnson P.H. Hirudin: amino-terminal residues play a major role in the interaction with thrombin. J. Biol. Chem. 266:1991;685-688
17. Wallace A., Dennis S., Hofsteenge J., Stone S.R. Contribution of the N-terminal region of hirudin to its interaction with thrombin. Biochemistry. 28:1989;10079-10084
18. Szarka S., Sihota E., Habibi H.R., Wong S.-L. Use of staphylokinase as a thrombolytic component of recombinant fusion proteins. Appl. Environ. Microbiol. 65:1999;506-513
19. Gite S., Reddy G., Shankar V. Active-site characterization of S1 nuclease. I. Affinity purification and influence of amino-group modification. Biochem. J. 285:1992;489-494
20. Colanduoni J., Villafranca J.J. Labeling of specific lysine residues at the active site of glutamine synthetase. J. Biol. Chem. 260:1985;15042-15050
21. Valentini G., De Gregorio A., Di Salvo C., Grimm R., Bellocco E., Cuzzocrea G., Iadarola P. An essential lysine in the substrate-binding site of ornithine carbamoyltransferase. Eur. J. Biochem. 239:1996;397-402
22. Lee Y.S., Mrksich M. Protein chips: from concept to practice. Trends Biotechnol. 20:2002;S14-S18
23. Zhu H., Snyder M. Protein chip technology. Curr. Opin. Chem. Biol. 7:2003;55-63
24. Wu S.-C., Yeung J.C., Hwang P.M., Wong S.-L. Design, production, and characterization of an engineered biotin ligase (bira) and its application for affinity purification of staphylokinase produced from Bacillus subtilis via secretion. Protein Expr. Purif. 24:2002;357-365
25. Schatz P.J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (NY). 11:1993;1138-1143
26. Wu S.-C., Wong S.-L. Development of improved pUB110-based vectors for expression and secretion studies in Bacillus subtilis. J. Biotechnol. 72:1999;185-195
27. Gill S.C., Von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326
28. Cull M.G., Schatz P.J. Biotinylation of proteins in vivo and in vitro using small peptide tags. Methods Enzymol. 326:2000;430-440
29. Issaq H.J., Veenstra T.D., Conrads T.P., Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292:2002;587-592
30. Merchant M., Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 21:2000;1164-1177
31. Wu S.-C., Ye R., Wu X.-C., Ng S.-C., Wong S.-L. Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones. J. Bacteriol. 180:1998;2830-2835
32. Chapman-Smith A., Cronan J.E. Jr. The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity. Trends Biochem. Sci. 24:1999;359-363
33. Cronan J.E. Jr., Reed K.E. Biotinylation of proteins in vivo: a useful posttranslational modification for protein analysis. Methods Enzymol. 326:2000;440-458
34. Chapman-Smith A., Cronan J.E. Jr. In vivo enzymatic protein biotinylation. Biomol. Eng. 16:1999;119-125
35. Wilson K.P., Shewchuk L.M., Brennan R.G., Otsuka A.J., Matthews B.W. Escherichia coli biotin holoenzyme synthetase/bio repressor crystal structure delineates the biotin- and DNA-binding domains. Proc. Natl. Acad. Sci. USA. 89:1992;9257-9261
36. Buoncristiani M.R., Howard P.K., Otsuka A.J. DNA-binding and enzymatic domains of the bifunctional biotin operon repressor (BirA) of Escherichia coli. Gene. 44:1986;255-261
37. Weaver L.H., Kwon K., Beckett D., Matthews B.W. Corepressor-induced organization and assembly of the biotin repressor: a model for allosteric activation of a transcriptional regulator. Proc. Natl. Acad. Sci. USA. 98:2001;6045-6050
38. Weaver L.H., Kwon K., Beckett D., Matthews B.W. Competing protein:protein interactions are proposed to control the biological switch of the E. coli biotin repressor. Protein Sci. 10:2001;2618-2622